| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/18/2006 | US20060105416 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 05/18/2006 | CA2587444A1 Guanidine derivatives as inhibitors of ddah |
| 05/18/2006 | CA2585983A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 05/17/2006 | EP1656361A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 05/17/2006 | EP1656350A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 05/17/2006 | EP1656144A2 Trp-p8 active compounds and therapeutic treatment methods |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP1140881B1 Antithrombotic amides |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/16/2006 | US7045653 Pharmaceuticals |
| 05/16/2006 | US7045636 MCH antagonists for the treatment of obesity |
| 05/16/2006 | US7045628 Synthesis of 2-aryl-1-naphthol derivatives via a tandem palladium catalyzed arylation and dehydrogenation |
| 05/16/2006 | US7045625 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 05/16/2006 | US7045551 such as (R)-N-[2-hydroxy-1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-propionamide; for treatment of migraines, bipolar disorders, epilepsy, acute/chronic pain and anxiety |
| 05/16/2006 | US7045540 Selective estrogen receptor modulators |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045524 Bactericides; infection therapy; topical administering |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/16/2006 | CA2192535C 2-naphtamides derivatives and therapeutic uses thereof |
| 05/11/2006 | WO2006050048A1 Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 05/11/2006 | WO2006049014A1 PROCESS FOR PRODUCING α,α-DIFLUOROAMINE |
| 05/11/2006 | US20060100298 Storage stability of photoinitiators |
| 05/11/2006 | US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid |
| 05/11/2006 | US20060100164 11-N-[4-(4-Pyridin-3-yl-imidazol-1-yl)-butyl]-6-O-methyl-5-O-(3-dimethylamino-2-hydroxy-propoxy)-3-oxo-erythronolide A, 11,12-carbamate; functionalized macrolides; antiviral, antiprotozoal, anticancer and antigastrointestinal |
| 05/11/2006 | CA2585615A1 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 05/10/2006 | EP1655303A2 Hydroxylamine esters as polimerization initiators |
| 05/10/2006 | EP1654324A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 05/10/2006 | EP1654225A2 Melanin concentrating hormone receptor antagonists |
| 05/10/2006 | EP1359892B1 Primary intermediates for oxidative coloration of hair |
| 05/10/2006 | EP1282630B1 Process for Reducing the Molecular Weight of Polypropylene Using Hydroxylamine Esters |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255391C COLCHINOL derivatives as vascular damaging agents |
| 05/10/2006 | CN1255383C Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators |
| 05/10/2006 | CN1255382C Modulators of dopamine neurotransmission |
| 05/09/2006 | US7041831 a [4-(5-phenyl)oxazolyl]-N-acetyl pyrrolidine or a [1-amino-2-hydroxy-2-phenylethyl]-N-acetyl pyrrolidine; enzyme inhibitors; anticarcinogenic, antitumor agents |
| 05/09/2006 | US7041830 oximation of isobutyl-(2-piperidinophenyl)-ketone with hydroxyl amine hydrochloride in an alcohol; reduction of oxime; solvent extraction, washing with brine, and evaporation; intermediate for the hypoglycemic agent, repaglinide; lower reaction temperatures; industrial scale synthesis |
| 05/09/2006 | US7041826 Process for preparing 1-methyl-3-phenylpiperazine using a novel intermediate |
| 05/09/2006 | US7041678 Alkaloid that inhibits biosynthesis of mycotoxins and method for screening for mycotoxin inhibitors |
| 05/04/2006 | WO2006047756A2 Substituted tetracycline compounds |
| 05/04/2006 | WO2006046131A1 Tetralin histamine-3 receptor antagonists |
| 05/04/2006 | WO2006045554A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/04/2006 | WO2006032994A3 Muscarinic receptor antagonists |
| 05/04/2006 | US20060094874 Novel substituted aryl alkenoic acid heterocyclic amides |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094718 O-substituted hydroxyaryl derivatives |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | CA2585248A1 Substituted tetracycline compounds |
| 05/04/2006 | CA2584664A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/03/2006 | EP1651597A2 N-sulphonylated amino acid derivatives, method for the production and use thereof |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | CN1768026A 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 05/03/2006 | CN1767823A Asthma and allergic inflammation modulators |
| 05/03/2006 | CN1765891A Novel aryloxy-alkyl-dialkylamines compound |
| 05/03/2006 | CN1765890A Modulators of dopamine neurotransmission |
| 05/03/2006 | CN1765874A Transition metallic catalyst ligand and its application method in cross coupled reaction |
| 05/03/2006 | CN1254469C Arylsulfonyl derivatives with 5-HT6 receptor affinity |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038084 Viricides; Aids therapy |
| 05/02/2006 | US7038074 Arginine mimetics as factor Xa inhibitors |
| 05/02/2006 | US7037941 Alpha-and Beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 05/02/2006 | US7037938 For therapy of urinary incontinence |
| 05/02/2006 | US7037913 Piperazinyl derivatives of naphthalenes, (iso)quinolines and naphthyridines; used particularly the treatment of HIV and AIDS. |
| 05/02/2006 | CA2326804C Compounds with activity on muscarinic receptors |
| 05/02/2006 | CA2206005C Aniline derivatives possessing an inhibitory effect of nitric oxide synthase |
| 04/27/2006 | WO2006044707A1 Chemical compounds |
| 04/27/2006 | WO2006044293A2 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | WO2006043691A1 Target protein and target gene in drug designing and screening method |
| 04/27/2006 | WO2006042678A1 Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid |
| 04/27/2006 | US20060089368 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/27/2006 | US20060089357 Novel compounds and compositions as cathepsin inhibitors |
| 04/27/2006 | US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/27/2006 | CA2583771A1 Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallization of salt and an aromatic sulfonic acid |
| 04/27/2006 | CA2583622A1 Ophthalmic compositions for treating ocular hypertension |
| 04/27/2006 | CA2583454A1 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/26/2006 | CN1764661A Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain. |
| 04/26/2006 | CN1762990A Valency platform molecules comprising aminooxy groups |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034158 Method of producing biperiden I |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034045 Monofluoroalkyl derivatives |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034020 inactivators of antigen-specific T cells; increased half-life |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/25/2006 | US7033578 Antimycotic nail varnish composition |
| 04/25/2006 | US7033564 Lithium aluminum hydride-based selenating reagent and preparation methods using same |
| 04/20/2006 | WO2006041888A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006040131A1 Iron or cobalt-catalyzed carbon-carbon coupling reaction of aryls, alkenes and alkines with copper reagents |
| 04/20/2006 | WO2006021655A3 Oxopiperidine derivatives, preparation and therapeutic use thereof |
| 04/20/2006 | WO2005082893A3 Histamine h3 receptor antagonists, preparation and therapeutic uses |
| 04/20/2006 | US20060084662 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder. |
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |